Pokii is a specialized health tracker for GLP-1 medication users, offering injection scheduling, level simulation, and progress logging on iOS.
The App DNA
What makes this app unique?
It removes the cognitive friction of tracking complex, multi-week injection cycles and relative side-effect changes that generic health apps fail to capture.
For Individuals managing GLP-1 medication routines for weight loss or diabetes who require specialized tracking for injections, side effects, and dosage levels.
What does it look like?
Key features
Visualizes projected medication levels to plan injection timing.
Logs side effects and mood using qualitative scales to lower logging friction.
Uses a visual body diagram for logging injection locations via direct tap.
How much does it cost?
Pokii operates as a free tool with no visible subscription or IAP gates, focusing on user acquisition.
Velocity
Maintenance developmentUX improvementsShow more...
The app currently operates at a maintenance cadence, with only one release shipped in the observed window. The latest release focused on minor adjustments to the deletion feedback sheet rather than new functional features. Development appears stable but limited to minor maintenance tasks. No significant feature expansion or live operations have been observed in recent updates.
Who built it?
Runpoint
3 apps tracked · Health & Fitness
Food Scanner & Calories-Bitix
Time To Wake Night Light AlarmUser Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for GLP-1 Tracker • Pokii
How's the Health & Fitness market?
Pokii holds a 4.75-star rating across 783 total ratings, establishing a strong reputation within the specialized GLP-1 tracking niche. The lack of monetization suggests a focus on user growth over immediate revenue capture.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for GLP-1 Tracker • Pokii
Where is it heading?
The GLP-1 tracking market is likely to consolidate as larger health platforms integrate specialized medication modules. Pokii's current maintenance-only cadence leaves it exposed to these incumbents, and the lack of a monetization model prevents the reinvestment required to defend its niche.
- The 25-day update cadence indicates a maintenance posture, which limits the app's ability to respond to new competitor features.
The SWOT
- Level simulation provides data-driven injection planning
- Visual site picker reduces logging friction
- Automated pharmacy data imports for dose logging
Next best moves
Implement optional premium tier because the current free-only model lacks revenue sustainability → secure long-term development
The counter-intuitive read
The absence of monetization is a strategic liability, not a growth advantage…
Read the full takeSince the last report: Pokii maintains a stable product posture with no functional updates, though the documentation now explicitly confirms Apple Health integration. The app continues to operate as a free, maintenance-mode tool while facing long-term sustainability risks.
Bottom line
Pokii serves a clear need for GLP-1 patients, but the lack of a monetization strategy leaves the product vulnerable to larger competitors. Implementing a sustainable revenue model would unlock the resources needed to move beyond maintenance-mode updates.
Unlock 2 critical frictions, 1 market threat and the analyst’s take.
Access the full report for freeSources
- [1] App Store, source
Report last updated